BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 29
• 30

• Drug Development

  Promising New Drug Blocks Mutation In Bone Marrow Cancers, Oregon Health & Science University (OHSU) Study

  December 15, 2008

   · 

  1 min read
• Fertile Women More Open To Corny Chat-Up Lines, University of South Brittany Study

  December 15, 2008

   · 

  1 min read
• FDA

  FDA Approves Eisai Corporation of North America’s LUSEDRA(TM) Injection for Monitored Anesthesia Care (MAC) Sedation

  December 15, 2008

   · 

  5 min read
• FDA

  FDA Approves Boston Scientific Corporation’s Express(R) SD Renal Stent System

  December 15, 2008

   · 

  5 min read
• Job Trends

  Titan Pharmaceuticals Announces Further Reductions in Workforce and Voluntary Delisting from the AMEX

  December 15, 2008

   · 

  2 min read
• Business

  Infosys Wins Deal from AstraZeneca PLC

  December 15, 2008

   · 

  1 min read
• Drug Development

  Novartis Corporation RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial

  December 15, 2008

   · 

  10 min read
• Biotech Beach

  Three Clinical Studies of bioTheranostics Molecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium

  December 15, 2008

   · 

  5 min read
• Drug Development

  Cylene Pharmaceuticals, Inc. Initiates Phase II Clinical Trial of Quarfloxin (CX-3543) in Patients With Carcinoid/Neuroendocrine Tumors

  December 15, 2008

   · 

  4 min read
• Lone Star Bio

  Genomic Health, Inc. Announces Study Establishing the Utility of Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated with Aromatase Inhibitors

  December 15, 2008

   · 

  7 min read